Medtronic Studies Cryoballoon As First-Line Atrial Fibrillation Option
This article was originally published in The Gray Sheet
The firm will recruit over 200 patients across 12 European sites to evaluate if its Arctic Front Advance ablation therapy can benefit as a first-line treatment for atrial fibrillation rather than drugs.
You may also be interested in...
Debuts include Medtronic’s next-generation Arctic Front Advance for paroxysmal atrial fibrillation, Covidien’s iDrive Ultra surgical stapler and AngioDynamics’ BioFlo peripherally inserted central catheters.
Atrial fibrillation treatments involving standalone surgical ablation and catheter ablation were discussed in data presentations at the American Heart Association annual meeting last week.
Artificial intelligence model’s comments signal the likely start of computer-generated comments to the US FDA’s public notices.